MYGN and SOPH Related Headlines

Go Back

Nov 3, 2025 04:05PM Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

Nov 3, 2025 04:05PM Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

Sep 23, 2025 08:01AM Myriad Genetics partners with SOPHiA GENETICS on liquid biopsy test

Sep 23, 2025 08:01AM Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

Sep 23, 2025 08:00AM Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

MYGN and SOPH Related Press Releases

Go Back

Nov 3, 2025 04:05PM Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

Nov 3, 2025 04:05PM Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

Sep 23, 2025 08:01AM Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

Sep 23, 2025 08:00AM Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

MYGN and SOPH Related SEC Filings

Go Back